NewsSource: EClinCloud Official Website Archive

EClinCloud at DIA Japan 2025 | Joining Global Partners to Discuss Clinical Research Innovation

1 min readEClinCloud Editorial Team
EClinCloud at DIA Japan 2025 | Joining Global Partners to Discuss Clinical Research Innovation — archive article cover

EClinCloud Gathers with Everyone in Tokyo

第22届DIA日本年会2025会场  

From October 19 to 21, the 22nd DIA Japan Annual Meeting was successfully held at Tokyo Big Sight. The theme of this annual meeting was: "A Strong Bond Connecting Japan, Asia, and the World—Co-creating a 'Future New Normal' to Benefit Patients."

As an organization at the forefront of international digital clinical research, EClinCloud participated deeply in this conference; the company's founder and expert team traveled to Tokyo in person to present China's innovative practices and achievements in digital clinical research to a global audience.

 

Cross-Border Dialogue: Building Bridges for Collaboration

During the exhibition, the EClinCloud booth attracted the attention of many pharmaceutical companies and partners. Industry experts from around the world stopped by for discussions and expressed strong recognition for EClinCloud's international project experience with products such as eCOA and eTMF, as well as the technical capabilities of its AI-driven intelligent platform.

一临云DIA Japan 2025展台  

 

Partnering Globally to Open a New Chapter in Clinical Research

EClinCloud continues to advance the globalization of its product and service ecosystem. The company's intelligent clinical cloud platform provides project support for global multicenter clinical trials; in particular, its full-lifecycle services exemplified by eCOA already cover multiple countries and regions worldwide. At the same time, we continue to build international project experience and establish new collaborations with more international pharmaceutical companies and CROs.

 

一临云英文产品与专业服务介绍  

 

EClinCloud consistently shares the latest developments in China's clinical research digitalization with global partners in a professional and open spirit, and looks forward to meeting again next time!

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.